Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man. 1982

D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin

The influence of age and obesity on glucose homeostasis may be mediated via changes in basal levels of the main glucoregulatory hormones, insulin, glucagon, and growth hormone. Fasting plasma levels of these hormones and of glucose were measured in 186 normal male volunteers, 23 to 93 years old. Obesity was assessed as obesity index and by a more accurate anthropometric method as percentage of fat. Age and obesity index had a significant but low linear correlation (r = -.16, p less than .05). Age was not significantly correlated to any other metabolic variable. Percentage of fat was, however, significantly related to the fasting plasma levels of glucose (r = .27, p less than .001), insulin (r = .26, p less than .01), and glucagon (r = .16 less than .05). Fasting glucose was significantly correlated to insulin (r = .30 , p less than .001). These significant correlations persisted when age was held constant. In the basal state the main glucoregulatory hormones are not influenced by age, but plasma glucose, insulin, and glucagon levels are influenced by obesity.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
February 1972, Archives of disease in childhood,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
November 1975, The Journal of clinical investigation,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
September 1979, Metabolism: clinical and experimental,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
August 1986, The Journal of clinical endocrinology and metabolism,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
April 1972, Archives of disease in childhood,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
November 1975, Israel journal of medical sciences,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
April 1981, European journal of clinical investigation,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
September 1977, Metabolism: clinical and experimental,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
January 1980, Journal of endocrinological investigation,
D Elahi, and D C Muller, and S P Tzankoff, and R Andres, and J D Tobin
October 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!